{"id":2,"date":"2019-04-19T17:32:39","date_gmt":"2019-04-19T17:32:39","guid":{"rendered":"https:\/\/www.cutaquigus.com\/hcp\/?page_id=2"},"modified":"2025-04-17T16:52:19","modified_gmt":"2025-04-17T16:52:19","slug":"home","status":"publish","type":"page","link":"https:\/\/cutaquigusa.com\/hcp\/","title":{"rendered":"Home"},"content":{"rendered":"\n<section id=\"block-1a\" class=\"block block--hero hero alignfull hero--2 hero--6 has-foreground-image\">\n<div class=\"hero__body\">\n<div class=\"alignwide\">\n<div class=\"hero__primary\">\n<div class=\"hero__media\"><\/div>\n<div class=\"hero__content\">\n<p>            <img class=\"hero__image\" alt=\"diver in water\" data-original=\"https:\/\/cutaquigusa.com\/wp-content\/uploads\/2019\/05\/diver-isolated.png\"><\/p>\n<h1 class=\"hero__headline\">\n<div class=\"hero__headline-lg\">In the treatment of Primary Immunodeficiency (PI)<br>in adults and pediatric patients 2 years of age and older<\/div>\n<div class=\"hero__subheadline\">confident. complete. <b>cutaquig.<\/b><\/div>\n<\/h1><p class=\"hero__excerpt p-lg\">Introducing a Subcutaneous Immune Globulin (SCIg) Therapy that Delivers Innovative Service and Support.<\/p>\n<p class=\"hero__excerpt p-lg\">Find info for Healthcare Professionals<\/p>\n\n<div class=\"hero__link\">\n            <a href=\"https:\/\/cutaquigusa.com\/hcp\/why-cutaquig\/\">\n<div class=\"action action--fa-angle-right\">Learn More <i class=\"fa fa-angle-right\"><\/i><\/div>\n<p>            <\/p><\/a>\n          <\/div>\n<\/div>\n<\/div>\n<div class=\"hero__ctas grid grid--even\">\n<div class=\"grid__item\">\n          <a class=\"cta\" href=\"https:\/\/cutaquigusa.com\/hcp\/why-cutaquig\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n<div class=\"cta__inner\">\n<h2 class=\"cta__title\">Deliver the complete package of care.<\/h2>\n<p class=\"cta__excerpt\">Learn more about cutaquig, for<br>adult&nbsp;and&nbsp;pediatric patients with PI.<\/p>\n<div class=\"cta__link-text btn-text btn-text--arrow\">Why Cutaquig?<\/div>\n<\/div>\n<p>          <\/p><\/a>\n        <\/div>\n<div class=\"grid__item\">\n          <a class=\"cta\" href=\"https:\/\/cutaquigusa.com\/hcp\/evidence\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n<div class=\"cta__inner\">\n<h2 class=\"cta__title\">Zero serious<br>bacterial infections.<sup>1<\/sup><\/h2>\n<p class=\"cta__excerpt\">Review the pivotal trial data demonstrating the clinical efficacy, tolerability and safety of cutaquig.<\/p>\n<div class=\"cta__link-text btn-text btn-text--arrow\">Evidence<\/div>\n<\/div>\n<p>          <\/p><\/a>\n        <\/div>\n<div class=\"grid__item\">\n          <a class=\"cta\" href=\"https:\/\/cutaquigusa.com\/hcp\/usage\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n<div class=\"cta__inner\">\n<h2 class=\"cta__title\">Convenient dosing and self-administration<\/h2>\n<p class=\"cta__excerpt\">Learn about cutaquig dosing when starting a patient on therapy for the first time or switching a patient from an intravenous imunoglobulin (IVIg) or another SCIg regimen, and get information on vial sizes, along with instructions on administration and handling.<\/p>\n<div class=\"cta__link-text btn-text btn-text--arrow\">Usage<\/div>\n<\/div>\n<p>          <\/p><\/a>\n        <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"block-2a\" class=\"block block--features alignfull\">\n<div class=\"alignwide\">\n<div class=\"grid grid--halves\">\n<div class=\"grid__item\">\n<div class=\"feature\">\n<div class=\"feature__body\">\n<h2 class=\"feature__headline\">IgCares<sup>&reg;<\/sup>: Full Circle Support for Your Patients<\/h2>\n<div class=\"feature__description\">IgCares, the patient support program from Octapharma, can help your patients at every step in their treatment journey. Designed with their needs in mind, IgCares offers opportunities for 1:1 clinical nurse support, self-infusion guidance, education, reimbursement and co-pay support, and more. Learn more about all the features and benefits available to your patients through membership in IgCares.<\/div>\n<p>            <a class=\"feature__link btn-text btn-text--arrow text--secondary\" href=\"https:\/\/cutaquigusa.com\/hcp\/patient-support\/igcares\/\">Learn More<\/a>\n          <\/p><\/div>\n<\/div>\n<\/div>\n<div class=\"grid__item\">\n<div class=\"feature\">\n<div class=\"feature__body\">\n<h2 class=\"feature__headline\">&ldquo;On-Call&rdquo; Clinical Nurse Educators<\/h2>\n<div class=\"feature__description\">You or your patients can connect with an Octapharma Clinical Nurse Educator for cutaquiq,or treatment-related questions or support.<\/div>\n<p>            <a class=\"feature__link btn-text btn-text--arrow text--secondary\" href=\"https:\/\/cutaquigusa.com\/hcp\/for-nurses\/talk-to-a-nurse-advisor\/\">Learn How it Works<\/a>\n          <\/p><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"block-3a\" class=\"block block--content alignfull\">\n<div class=\"block__content-wrapper alignwide \">\n<div class=\"aligndefault\">\n<h5>References:<\/h5>\n<ol>\n<li class=\"small\">Kobayashi RH, Gupta S, Melamed I, et al. Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (octanorm [cutaquig&reg;]) in the Treatment of Patients with Primary Immunodeficiencies. Front Immunol. February 2019 | Volume 10 | Article 40.<\/li>\n<\/ol><\/div>\n<\/div>\n<\/section>\n\n","protected":false},"excerpt":{"rendered":"<p>In the treatment of Primary Immunodeficiency (PI)in adults and pediatric patients 2 years of age and older confident. complete. cutaquig&#8230;.<\/p>\n","protected":false},"author":29,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae<\/title>\n<meta name=\"description\" content=\"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cutaquigusa.com\/hcp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae\" \/>\n<meta property=\"og:description\" content=\"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cutaquigusa.com\/hcp\/\" \/>\n<meta property=\"og:site_name\" content=\"cutaquig\u00ae Healthcare Professionals\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/igcares\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-17T16:52:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_1200x675.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_1200x675.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\",\"url\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\",\"name\":\"Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cutaquigusa.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/diver-isolated.png\",\"datePublished\":\"2019-04-19T17:32:39+00:00\",\"dateModified\":\"2025-04-17T16:52:19+00:00\",\"description\":\"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cutaquigusa.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/diver-isolated.png\",\"contentUrl\":\"https:\\\/\\\/cutaquigusa.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/diver-isolated.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#website\",\"url\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\",\"name\":\"cutaquig\u00ae Healthcare Professionals\",\"description\":\"Cutaquig\u00ae [Immune Globulin Subcutaneous (Human) - hipp]\",\"publisher\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#organization\",\"name\":\"Cutaquig\u00ae\",\"url\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/01\\\/cutaquig_logo_696x696.jpg\",\"contentUrl\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/01\\\/cutaquig_logo_696x696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Cutaquig\u00ae\"},\"image\":{\"@id\":\"https:\\\/\\\/cutaquigusa.com\\\/hcp\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/igcares\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae","description":"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cutaquigusa.com\/hcp\/","og_locale":"en_US","og_type":"article","og_title":"Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae","og_description":"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.","og_url":"https:\/\/cutaquigusa.com\/hcp\/","og_site_name":"cutaquig\u00ae Healthcare Professionals","article_publisher":"https:\/\/www.facebook.com\/igcares","article_modified_time":"2025-04-17T16:52:19+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_1200x675.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_1200x675.jpg","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/cutaquigusa.com\/hcp\/","url":"https:\/\/cutaquigusa.com\/hcp\/","name":"Subcutaneous Immunoglobulin Therapy Info for HCP | cutaquig\u00ae","isPartOf":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#primaryimage"},"image":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#primaryimage"},"thumbnailUrl":"https:\/\/cutaquigusa.com\/wp-content\/uploads\/2019\/05\/diver-isolated.png","datePublished":"2019-04-19T17:32:39+00:00","dateModified":"2025-04-17T16:52:19+00:00","description":"Learn about cutaquig\u00ae (Immune Globulin Subcutaneous [Human]-hipp, 16.5% solution) SCIg therapy. Please see Important Safety Info including boxed warning.","breadcrumb":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cutaquigusa.com\/hcp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cutaquigusa.com\/hcp\/#primaryimage","url":"https:\/\/cutaquigusa.com\/wp-content\/uploads\/2019\/05\/diver-isolated.png","contentUrl":"https:\/\/cutaquigusa.com\/wp-content\/uploads\/2019\/05\/diver-isolated.png"},{"@type":"BreadcrumbList","@id":"https:\/\/cutaquigusa.com\/hcp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cutaquigusa.com\/hcp\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/cutaquigusa.com\/hcp\/#website","url":"https:\/\/cutaquigusa.com\/hcp\/","name":"cutaquig\u00ae Healthcare Professionals","description":"Cutaquig\u00ae [Immune Globulin Subcutaneous (Human) - hipp]","publisher":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cutaquigusa.com\/hcp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cutaquigusa.com\/hcp\/#organization","name":"Cutaquig\u00ae","url":"https:\/\/cutaquigusa.com\/hcp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cutaquigusa.com\/hcp\/#\/schema\/logo\/image\/","url":"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_696x696.jpg","contentUrl":"https:\/\/cutaquigusa.com\/hcp\/wp-content\/uploads\/sites\/2\/2025\/01\/cutaquig_logo_696x696.jpg","width":696,"height":696,"caption":"Cutaquig\u00ae"},"image":{"@id":"https:\/\/cutaquigusa.com\/hcp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/igcares"]}]}},"_links":{"self":[{"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":0,"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"wp:attachment":[{"href":"https:\/\/cutaquigusa.com\/hcp\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}